|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/443 | |
| A61P 35/02 | |||
| C07D 405/12 |
| (11) | Patento numeris | 3329917 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16830602.5 |
| Europos patento paraiškos padavimo data | 2016-07-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2016/072262 |
| Data | 2016-07-29 |
| (87) | Numeris | WO 2017/018499 |
| Data | 2017-02-02 |
| (30) | Numeris | Data | Šalis |
| 2015151170 | 2015-07-30 | JP |
| (72) |
WATANABE, Toshiki, JP
YAMAGISHI, Makoto, JP
KANNO, Osamu, JP
WATANABE, Jun, JP
ADACHI, Nobuaki, JP
HONMA, Daisuke, JP
HAMADA, Yoshito, JP
|
| (73) |
Daiichi Sankyo Company, Limited,
3-5-1, Nihonbashi Honcho Chuo-ku, Tokyo 103-8426,
JP
The University Of Tokyo, 3-1 Hongo 7-chome Bunkyo-ku, Tokyo 113-8654, JP |
| (54) | THERAPEUTIC AND/OR PROPHYLACTIC AGENT FOR ADULT T CELL LEUKEMIA/LYMPHOMA |
| THERAPEUTIC AND/OR PROPHYLACTIC AGENT FOR ADULT T CELL LEUKEMIA/LYMPHOMA |